Safety and efficacy of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune disease: A systematic review and meta-analysis in non-small cell lung cancer

被引：0
|
作者：
Aung, Wint Yan
Lee, Chung-Shien
Morales, Jaclyn
Kohn, Nina
Rahman, Husneara
Seetharamu, Nagashree
机构：
[1] Northwell Hlth, Manhasset, NY USA
[2] Northwell Hlth Canc Inst, New Hyde Pk, NY USA
[3] Feinstein Inst Med Res, Manhasset, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9053
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Impact of proton-pump inhibitors on the efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis
    Dar, Sophia
    Merza, Nooraldin
    Rahim, Mehek
    Qatani, Ahmad
    Varughese, Tony
    Mohammad, Asna
    Masood, Fahad
    Reza, Fizza
    Wan, Schuchen
    Almas, Talal
    Ellahi, Aayat
    Ligresti, Rosario
    [J]. ANNALS OF MEDICINE AND SURGERY, 2022, 78
  • [22] Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
    Wang, Shuai
    Hao, Jiatao
    Wang, Hao
    Fang, Yong
    Tan, Lijie
    [J]. ONCOIMMUNOLOGY, 2018, 7 (08):
  • [23] Safety and efficacy of restarting immune checkpoint inhibitors in non-small cell lung cancer patients following immune-related adverse events: a systematic review and meta-analysis
    Tan, Kexin
    Wang, Aolin
    Zheng, Yumin
    Wang, Shuo
    Wang, Chao
    Li, Jia
    Lu, Xingyu
    Dong, Huijing
    Zheng, Jiabin
    Cui, Huijuan
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [24] Comparative safety of immune checkpoint inhibitors and chemotherapy in advanced non-small cell lung cancer: A systematic review and network meta-analysis
    Chen, Ching-Yi
    Huang, Chi-Hsien
    Chen, Wang-Chun
    Huang, Ming-Shyan
    Wei, Yu-Feng
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 108
  • [25] The effect of smoking status on efficacy of immune checkpoint inhibitors in metastatic non-small cell lung cancer: A systematic review and meta-analysis
    Dai, Linzheng
    Jin, Bo
    Liu, Tingting
    Chen, Jun
    Li, Guang
    Dang, Jun
    [J]. ECLINICALMEDICINE, 2021, 38
  • [26] Sarcopenia as a Determinant of the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: A Meta-Analysis
    Ren, Bixin
    Shen, Jiucheng
    Qian, Yajuan
    Zhou, Tong
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2023, 75 (02): : 685 - 695
  • [27] Vascular events with immune checkpoint inhibitors in melanoma or non-small cell lung cancer: A systematic review and meta-analysis
    Giustozzi, Michela
    Becattini, Cecilia
    Roila, Fausto
    Agnelli, Giancarlo
    Mandala, Mario
    [J]. CANCER TREATMENT REVIEWS, 2021, 100
  • [28] Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis
    Guaitoli, Giorgia
    Tiseo, Marcello
    Di Maio, Massimo
    Friboulet, Luc
    Facchinetti, Francesco
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) : 2890 - 2916
  • [29] Efficacy and safety of angiogenesis inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis
    Hong, Shaodong
    Tan, Min
    Wang, Shouzheng
    Luo, Shengyuan
    Chen, Yue
    Zhang, Li
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (05) : 909 - 921
  • [30] Efficacy and safety of angiogenesis inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis
    Shaodong Hong
    Min Tan
    Shouzheng Wang
    Shengyuan Luo
    Yue Chen
    Li Zhang
    [J]. Journal of Cancer Research and Clinical Oncology, 2015, 141 : 909 - 921
12345